TY - JOUR
T1 - Stepwise Confidence Intervals without Multiplicity Adjustment for Dose—Response and Toxicity Studies
AU - Hsu, Jason C.
AU - Berger, Roger L.
PY - 1999/6/1
Y1 - 1999/6/1
N2 - Not all simultaneous inferences need multiplicity adjustment. If the sequence of individual inferences is predefined, and failure to achieve the desired inference at any step renders subsequent inferences unnecessary, then multiplicity adjustment is not needed. This can be justified using the closed testing principle to test appropriate hypotheses that are nested in sequence, starting with the most restrictive one. But what hypotheses are appropriate may not be obvious in some problems. We give a fundamentally different, confidence set–based justification by partitioning the parameter space naturally and using the principle that exactly one member of the partition contains the true parameter. In dose–response studies designed to show superiority of treatments over a placebo (negative control) or a drug known to be efficacious (active control), the confidence set approach generates methods with meaningful guarantee against incorrect decision, whereas previous applications of the closed testing approach have not always done so. Application of the confidence set approach to toxicity studies designed to show equivalence of treated groups with a placebo is also given.
AB - Not all simultaneous inferences need multiplicity adjustment. If the sequence of individual inferences is predefined, and failure to achieve the desired inference at any step renders subsequent inferences unnecessary, then multiplicity adjustment is not needed. This can be justified using the closed testing principle to test appropriate hypotheses that are nested in sequence, starting with the most restrictive one. But what hypotheses are appropriate may not be obvious in some problems. We give a fundamentally different, confidence set–based justification by partitioning the parameter space naturally and using the principle that exactly one member of the partition contains the true parameter. In dose–response studies designed to show superiority of treatments over a placebo (negative control) or a drug known to be efficacious (active control), the confidence set approach generates methods with meaningful guarantee against incorrect decision, whereas previous applications of the closed testing approach have not always done so. Application of the confidence set approach to toxicity studies designed to show equivalence of treated groups with a placebo is also given.
UR - http://www.scopus.com/inward/record.url?scp=1542742904&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1542742904&partnerID=8YFLogxK
U2 - 10.1080/01621459.1999.10474141
DO - 10.1080/01621459.1999.10474141
M3 - Article
AN - SCOPUS:1542742904
SN - 0162-1459
VL - 94
SP - 468
EP - 482
JO - Journal of the American Statistical Association
JF - Journal of the American Statistical Association
IS - 446
ER -